The Negrar Hospital joins the largest Italian cancer research network which includes another 27 Irccs. The “Sacro Cuore Don Calabria” is recognized as an IRCCS for infectious and tropical diseases and has joined the Alliance Against Cancer as it meets all the requirements for Oncological Scientific Hospitalization and Treatment Institutes.
The IRCCS Sacro Cuore Don Calabria Hospital joins the Alliance Against Cancer (ACC), the largest Italian cancer research organization.Founded in 2002 by the Ministry of Health, its objective is to promote collaboration between oncological IRCCS in order to increase research for diagnostic and therapeutic purposes.
The founding members were the Regina Elena National Cancer Institute in Rome, the San Martino Polyclinic in Genoa, the Pascale Foundation in Naples, the Oncological Reference Center in Aviano and the John Paul II Oncological Institute in Bari.
of ACC 27 Scientific Hospitalization and Care Institutes (IRCCS), constituting a network that numerically translates into 7,600 researchers, 5,100 publications, 150,000 hospitalizations and 4,400 clinical studies per year.
“Joining the Alliance Against Cancer is a prestigious attestation of the value of the activity carried out so far by our hospital as a Cancer Care Center – says Dr. Stefania Gori, director of the Oncology Department -. An acknowledgment that rewards all the Operative Units of the “Sacred Heart of Don Calabria” engaged in diagnostics, treatment and research on tumors.
At the same time, it is a great opportunity for development in these three areas of oncological activity, because only by networking and thus sharing knowledge can people with oncological disease be effectively treated “.
The “Sacro Cuore Don Calabria” is recognized as IRCCS for infectious and tropical diseases and has joined the Alliance Against Cancer as it meets all the requirements for Oncological Scientific Hospitalization and Treatment Institutes: from hospitalization activities to technological equipment, from research activities to scientific publications.
Negrar Hospital is currently involved in “Health Big Data”, a joint project of the IRCCS networks of the Alliance Against Cancer, of Neuroscience and Rehabilitation and of Cardiology.
With a ten-year duration, it aims to create a technological platform that allows the collection, sharing and analysis of clinical and scientific data of the patients of each IRCCS in order to accelerate the transition to precision and personalized medicine. Which means disease prevention, personalization of care and improvement of patients’ quality of life.
We all look forward to the fundamental preventive measure at Covid which is vaccination. In the meantime, or immediately after, it may be helpful to pay attention to another important aspect for our health: “recovering” the checks and examinations neglected during the pandemic, especially those concerning cancer prevention.
In fact, in the first nine months of 2020 alone, two million fewer cancer screenings were performed than in the previous year: in practice, one exam in five, among those scheduled, was “skipped”.
This data, taken from the recently published second report of the National Screening Observatory, raises great concerns about what will be one of the most serious consequences of the Covid emergency, the increase in tumors not diagnosed at an early stage and therefore much more difficult to treat.
A phenomenon, according to specialists, which will be dramatically visible in the second half of this year and especially in 2022 and which is destined to worsen in this further period of emergency.
Hence the appeal of specialists, on the occasion of the Cancer Prevention Week, promoted by Lilt (Italian League for the fight against cancer) not to neglect primary prevention (healthy nutrition and correct lifestyle) and early diagnosis.
The data of the Observatory then concern the three main screenings, i.e. those that are provided for by the National Health Service: mammography, the Pap test (now connected with the
HPV test, i.e. the papillomavirus) for the control of the uterus, and the search for occult blood in the faeces (and possibly colonoscopy) for colorectal cancers. In these cases, in most regions, citizens are urged and invited to undergo checks and everywhere, despite hospital problems, many dedicated structures have remained active.
But the fear of Covid seems to have raised a barrier and made us forget an equally important prevention. Then there are many other forms of cancer, whose control is not part of the screening of the Health Service and for which the situation could be even more serious.